Dr. Fleddermann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4330 Wornall Rd
Ste 2000
Kansas City, MO 64111Phone+1 816-931-1883
Education & Training
University of Missouri-Kansas City School of MedicineFellowship, Cardiovascular Disease, 2016 - 2019
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2013 - 2016- University of Missouri Kansas City School of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2024 - 2026
KS State Medical License 2019 - 2025
MN State Medical License 2024 - 2025
MO State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- A novel echocardiographic approach for assessing coronary artery origins.Christopher DeZorzi, Alan Marsh, Tracy Binkley, Adam Fleddermann, Travis Gratton
Echocardiography. 2021-05-28 - Authors' Reply to "Underlying Differences in the Treatment of Left Ventricular Thrombus With Non-Vitamin K Antagonist Oral Anticoagulants".Adam Fleddermann, Charles Hayes, Anthony Magalski, Michael L. Main
The American Journal of Cardiology. 2019-08-24 - 64 citationsEfficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus.Adam Fleddermann, Charles Hayes, Anthony Magalski, Michael L. Main
The American Journal of Cardiology. 2019-08-01
Press Mentions
Lee’s Summit Construction Worker Survives Rare Heart Disease After Heart Stopped TwiceFebruary 21st, 2020
DOACs Safe, Effective in A-fib Patients with Preexisting LAA ThrombusOctober 4th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
